{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:05:21Z","timestamp":1788566721362,"version":"build-2803163510"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.01742","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:59:30Z","timestamp":1599613170000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["The Use of Immunohistochemistry, Fluorescence in situ Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review"],"prefix":"10.3389","volume":"10","author":[{"given":"Eric","family":"Rozitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuen Yee","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/jama.1964.03060270028006","article-title":"Asbestos exposure and neoplasia.","volume":"188","author":"Selikoff","year":"1964","journal-title":"JAMA."},{"key":"B2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5858\/arpa.2017-0124-ra","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group.","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"v31","DOI":"10.1093\/annonc\/mdv199","article-title":"Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.","volume":"26","author":"Baas","year":"2015","journal-title":"Ann Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2147\/clep.s105396","article-title":"Mesothelioma in the United States: a surveillance, epidemiology, and end results (SEER)-Medicare investigation of treatment patterns and overall survival.","volume":"8","author":"Beebe-Dimmer","year":"2016","journal-title":"Clin Epidemiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.lungcan.2018.07.041","article-title":"Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic\/molecular analysis of malignant mesothelioma subtypes.","volume":"124","author":"Churg","year":"2018","journal-title":"Lung Cancer."},{"key":"B6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/jto.0000000000000471","article-title":"High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma.","volume":"10","author":"Nasu","year":"2015","journal-title":"J Thorac Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry.","volume":"104","author":"Hida","year":"2017","journal-title":"Lung Cancer."},{"key":"B8","first-page":"2108","article-title":"Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.","volume":"9","author":"Illei","year":"2003","journal-title":"Clin Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1378\/chest.09-1951","article-title":"Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology.","volume":"138","author":"Savic","year":"2010","journal-title":"Chest."},{"key":"B10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/modpathol.2008.45","article-title":"Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas.","volume":"21","author":"Chiosea","year":"2008","journal-title":"Mod Pathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/cncy.21928","article-title":"A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.","volume":"126","author":"Kinoshita","year":"2018","journal-title":"Cancer Cytopathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41379-019-0310-0","article-title":"MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma.","volume":"33","author":"Chapel","year":"2020","journal-title":"Mod Pathol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/pin.12453","article-title":"BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests.","volume":"66","author":"Hida","year":"2016","journal-title":"Pathol Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.5858\/arpa.2018-0273-oa","article-title":"Utility of methylthioadenosine phosphorylase compared with BAP1 immunohistochemistry, and CDKN2A and NF2 fluorescence in situ hybridization in separating reactive mesothelial proliferations from epithelioid malignant mesotheliomas.","volume":"142","author":"Berg","year":"2018","journal-title":"Arch Pathol Lab Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/jclinpath-2012-201303","article-title":"Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.","volume":"66","author":"Henderson","year":"2013","journal-title":"J Clin Pathol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4103\/1742-6413.170726","article-title":"Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.","volume":"12","author":"Hjerpe","year":"2015","journal-title":"Cytojournal."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5146\/tjpath.2014.01158","article-title":"The diagnosis of thoracic malignant mesothelioma: practical considerations and recent developments.","volume":"30","author":"Smith","year":"2014","journal-title":"Turk Patoloji Derg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/modpathol.2012.200","article-title":"Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas.","volume":"26","author":"Ordonez","year":"2013","journal-title":"Mod Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.humpath.2009.06.014","article-title":"Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.","volume":"41","author":"Bishop","year":"2010","journal-title":"Hum Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.humpath.2014.03.006","article-title":"Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study.","volume":"45","author":"Ordonez","year":"2014","journal-title":"Hum Pathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/pai.0b013e3182025f66","article-title":"Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study.","volume":"19","author":"Tacha","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1097\/pas.0000000000000935","article-title":"PAX8 expression in a subset of malignant peritoneal mesotheliomas and benign mesothelium has diagnostic implications in the differential diagnosis of ovarian serous carcinoma.","volume":"41","author":"Chapel","year":"2017","journal-title":"Am J Surg Pathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.5858\/arpa.2018-0020-ra","article-title":"Cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: ten years of clinical experience in relation to international guidelines.","volume":"142","author":"Hjerpe","year":"2018","journal-title":"Arch Pathol Lab Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.5858\/arpa.2015-0240-sa","article-title":"New markers for separating benign from malignant mesothelial proliferations: are we there yet?","volume":"140","author":"Churg","year":"2016","journal-title":"Arch Pathol Lab Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet."},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.","volume":"10","author":"Carbone","year":"2012","journal-title":"J Transl Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/pas.0000000000000529","article-title":"Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens.","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1097\/pas.0000000000000616","article-title":"BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of sarcomatous and desmoplastic mesotheliomas.","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/pas.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations.","volume":"39","author":"Sheffield","year":"2015","journal-title":"Am J Surg Pathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/jto.0000000000000436","article-title":"Targeted next-generation sequencing of cancer genes in advanced stage malignant pleural mesothelioma: a retrospective study.","volume":"10","author":"Lo Iacono","year":"2015","journal-title":"J Thorac Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1158\/0008-5472.can-05-3907","article-title":"Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.","volume":"66","author":"Lopez-Rios","year":"2006","journal-title":"Cancer Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/modpathol.2009.186","article-title":"CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival.","volume":"23","author":"Krasinskas","year":"2010","journal-title":"Mod Pathol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1309\/ajcpt94jvwihbkrd","article-title":"Diagnostic usefulness of p16\/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis.","volume":"139","author":"Wu","year":"2013","journal-title":"Am J Clin Pathol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.1111\/j.1365-2559.2012.04196.x","article-title":"The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas.","volume":"60","author":"Zimling","year":"2012","journal-title":"Histopathology."},{"key":"B35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/modpathol.2015.121","article-title":"The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.","volume":"29","author":"Singhi","year":"2016","journal-title":"Mod Pathol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.lungcan.2008.08.014","article-title":"Functional inactivation of NF2\/merlin in human mesothelioma.","volume":"64","author":"Thurneysen","year":"2009","journal-title":"Lung Cancer."},{"key":"B37","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.21037\/jtd.2018.08.59","article-title":"Role of p16 deletion and BAP1 loss in the diagnosis of malignant mesothelioma.","volume":"10","author":"Liu","year":"2018","journal-title":"J Thorac Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"9073","DOI":"10.1158\/0008-5472.can-09-1595","article-title":"Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.","volume":"69","author":"Goto","year":"2009","journal-title":"Cancer Res."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070940","article-title":"Long non coding RNAs (lncRNAs) are dysregulated in malignant pleural mesothelioma (MPM).","volume":"8","author":"Wright","year":"2013","journal-title":"PLoS One."},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2536187","article-title":"SFRP tumour suppressor genes are potential plasma-based epigenetic biomarkers for malignant pleural mesothelioma.","volume":"2017","author":"Cheng","year":"2017","journal-title":"Dis Markers."},{"key":"B41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy.","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/jto.0b013e3182a0840a","article-title":"ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.","volume":"8","author":"Cheng","year":"2013","journal-title":"J Thorac Oncol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc2876","article-title":"Covalent histone modifications\u2013miswritten, misinterpreted and mis-erased in human cancers.","volume":"10","author":"Chi","year":"2010","journal-title":"Nat Rev Cancer."},{"key":"B44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1158\/0008-5472.can-08-2586","article-title":"Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome.","volume":"69","author":"Christensen","year":"2009","journal-title":"Cancer Res."},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9645940","article-title":"MicroRNA Expression in malignant pleural mesothelioma and asbestosis: a pilot study.","volume":"2017","author":"Mozzoni","year":"2017","journal-title":"Dis Markers."},{"key":"B46","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1160\/th11-12-0836","article-title":"Regulation of microRNA biogenesis and function.","volume":"107","author":"Treiber","year":"2012","journal-title":"Thromb Haemost."},{"key":"B47","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1579490","article-title":"Circular RNA-ITCH suppresses lung cancer proliferation via inhibiting the wnt\/beta-catenin pathway.","volume":"2016","author":"Wan","year":"2016","journal-title":"Biomed Res Int."},{"key":"B48","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/onc.2017.361","article-title":"Circular RNAs in cancer: opportunities and challenges in the field.","volume":"37","author":"Kristensen","year":"2018","journal-title":"Oncogene."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/ijc.23173","article-title":"Inflammation and cancer: an ancient link with novel potentials.","volume":"121","author":"Hussain","year":"2007","journal-title":"Int J Cancer."},{"key":"B50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jso.20266","article-title":"Malignant peritoneal mesothelioma.","volume":"91","author":"Bani-Hani","year":"2005","journal-title":"J Surg Oncol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2017.06.60","article-title":"Diagnosis and prognosis-review of biomarkers for mesothelioma.","volume":"5","author":"Sun","year":"2017","journal-title":"Ann Transl Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","article-title":"The fundamental role of epigenetic events in cancer.","volume":"3","author":"Jones","year":"2002","journal-title":"Nat Rev Genet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1006\/scbi.1999.0135","article-title":"CpG island methylator phenotypes in aging and cancer.","volume":"9","author":"Toyota","year":"1999","journal-title":"Semin Cancer Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/j.1745-7254.2007.00692.x","article-title":"Roles of secreted frizzled-related proteins in cancer.","volume":"28","author":"Shi","year":"2007","journal-title":"Acta Pharmacol Sin."},{"key":"B55","doi-asserted-by":"publisher","first-page":"6672","DOI":"10.1038\/sj.onc.1207881","article-title":"Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma.","volume":"23","author":"Lee","year":"2004","journal-title":"Oncogene."},{"key":"B56","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/bjc.2013.393","article-title":"Molecular sputum analysis for the diagnosis of lung cancer.","volume":"109","author":"Hubers","year":"2013","journal-title":"Br J Cancer."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149756","article-title":"Multiplex PCR and next generation sequencing for the non-invasive detection of bladder cancer.","volume":"11","author":"Ward","year":"2016","journal-title":"PLoS One."},{"key":"B58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1158\/1078-0432.CCR-18-0843","article-title":"A noninvasive blood-based combinatorial proteomic biomarker assay to detect breast cancer in women over age 50 with BI-RADS 3, 4, or 5 assessment.","volume":"25","author":"Henderson","year":"2019","journal-title":"Clin Cancer Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.atg.2015.08.006","article-title":"Highly sensitive, non-invasive detection of colorectal cancer mutations using single molecule, third generation sequencing.","volume":"7","author":"Russo","year":"2015","journal-title":"Appl Transl Genom."},{"key":"B60","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jtho.2018.10.163","article-title":"Peripheral Blood DNA methylation as potential biomarker of malignant pleural mesothelioma in asbestos-exposed subjects.","volume":"14","author":"Guarrera","year":"2019","journal-title":"J Thorac Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.mcn.2004.01.004","article-title":"The role of Zic genes in neural development.","volume":"26","author":"Aruga","year":"2004","journal-title":"Mol Cell Neurosci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3892\/or_00000875","article-title":"Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.","volume":"24","author":"Kohno","year":"2010","journal-title":"Oncol Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1002\/ijc.25285","article-title":"Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma.","volume":"127","author":"Gee","year":"2010","journal-title":"Int J Cancer."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.","volume":"24","author":"Reid","year":"2013","journal-title":"Ann Oncol."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00650","article-title":"MicroRNAs for the diagnosis and management of malignant pleural mesothelioma: a literature review.","volume":"8","author":"Lo Russo","year":"2018","journal-title":"Front Oncol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.4161\/cc.10.13.15712","article-title":"MicroRNAs and lung cancer: from markers to targets.","volume":"10","author":"Sozzi","year":"2011","journal-title":"Cell Cycle."},{"key":"B67","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1158\/0008-5472.CAN-08-4277","article-title":"miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.","volume":"69","author":"Bandi","year":"2009","journal-title":"Cancer Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.2741\/4068","article-title":"MicroRNAs: molecular features and role in cancer.","volume":"17","author":"Lages","year":"2012","journal-title":"Front Biosci (Landmark Ed)."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3892\/ijmm.2015.2379","article-title":"Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.","volume":"36","author":"Wu","year":"2015","journal-title":"Int J Mol Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/gcc.21957","article-title":"Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.","volume":"51","author":"Slaby","year":"2012","journal-title":"Genes Chromosomes Cancer."},{"key":"B71","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1995-7645(14)60323-0","article-title":"MicroRNA-126 inhibits the proliferation of lung cancer cell line A549.","volume":"8","author":"Yang","year":"2015","journal-title":"Asian Pac J Trop Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.lungcan.2009.01.010","article-title":"MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo.","volume":"66","author":"Liu","year":"2009","journal-title":"Lung Cancer."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/onc.2013.42","article-title":"Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer.","volume":"33","author":"Wang","year":"2014","journal-title":"Oncogene."},{"key":"B74","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.lungcan.2015.09.021","article-title":"Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma.","volume":"90","author":"Santarelli","year":"2015","journal-title":"Lung Cancer."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8628612","article-title":"MicroRNA signatures in malignant pleural mesothelioma effusions.","volume":"2019","author":"Birnie","year":"2019","journal-title":"Dis Markers."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02694-0","article-title":"Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism.","volume":"7","author":"De Santi","year":"2017","journal-title":"Sci Rep."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code.","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science."},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ht7030020","article-title":"Genomics and epigenetics of malignant mesothelioma.","volume":"7","author":"Sage","year":"2018","journal-title":"High Throughput."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/cbic.201402313","article-title":"Traceless semisynthesis of a set of histone 3 species bearing specific lysine methylation marks.","volume":"15","author":"Chen","year":"2014","journal-title":"Chembiochem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1158\/1535-7163.MCT-09-0138","article-title":"The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer.","volume":"8","author":"Crisanti","year":"2009","journal-title":"Mol Cancer Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/JTO.0b013e3181c5e366","article-title":"Histone deacetylase inhibitors in malignant pleural mesothelioma: preclinical rationale and clinical trials.","volume":"5","author":"Paik","year":"2010","journal-title":"J Thorac Oncol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1745-7270.2007.00363.x","article-title":"Reversible histone acetylation involved in transcriptional regulation of WT1 gene.","volume":"39","author":"Shao","year":"2007","journal-title":"Acta Biochim Biophys Sin (Shanghai)."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1386","article-title":"Emerging roles and context of circular RNAs.","volume":"8","author":"Panda","year":"2017","journal-title":"Wiley Interdiscip Rev RNA."},{"key":"B84","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2890","article-title":"Detecting and characterizing circular RNAs.","volume":"32","author":"Jeck","year":"2014","journal-title":"Nat Biotechnol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell."},{"key":"B86","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrm.2015.32","article-title":"The biogenesis and emerging roles of circular RNAs.","volume":"17","author":"Chen","year":"2016","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.celrep.2016.03.058","article-title":"The biogenesis of nascent circular RNAs.","volume":"15","author":"Zhang","year":"2016","journal-title":"Cell Rep."},{"key":"B88","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","article-title":"Circular RNAs are abundant, conserved, and associated with ALU repeats.","volume":"19","author":"Jeck","year":"2013","journal-title":"RNA."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0409-z","article-title":"Expanded identification and characterization of mammalian circular RNAs.","volume":"15","author":"Guo","year":"2014","journal-title":"Genome Biol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1261\/rna.2248605","article-title":"MicroRNA function: multiple mechanisms for a tiny RNA?","volume":"11","author":"Pillai","year":"2005","journal-title":"RNA."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/genes8120353","article-title":"Circular RNAs (circRNAs) in health and disease.","volume":"8","author":"Haque","year":"2017","journal-title":"Genes (Basel)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges.","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.18632\/oncotarget.22846","article-title":"Circular RNAs: clinical relevance in cancer.","volume":"9","author":"Xu","year":"2018","journal-title":"Oncotarget."},{"key":"B94","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","article-title":"Exon-intron circular RNAs regulate transcription in the nucleus.","volume":"22","author":"Li","year":"2015","journal-title":"Nat Struct Mol Biol."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0801-3","article-title":"Spatio-temporal regulation of circular RNA expression during porcine embryonic brain development.","volume":"16","author":"Veno","year":"2015","journal-title":"Genome Biol."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb0217-194a","article-title":"Corrigendum: exon-intron circular RNAs regulate transcription in the nucleus.","volume":"24","author":"Li","year":"2017","journal-title":"Nat Struct Mol Biol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1158\/1078-0432.CCR-16-2541","article-title":"Circular RNA ciRS-7-A promising prognostic biomarker and a potential therapeutic target in colorectal cancer.","volume":"23","author":"Weng","year":"2017","journal-title":"Clin Cancer Res."},{"key":"B98","first-page":"82","article-title":"Circular RNAs as novel biomarkers for detection of malignant pleural mesothelioma.","volume":"14","author":"Winata","year":"2018","journal-title":"Asia Paci J Clin Oncol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1261\/rna.043687.113","article-title":"circBase: a database for circular RNAs.","volume":"20","author":"Glazar","year":"2014","journal-title":"RNA."},{"key":"B100","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15476286.2015.1128065","article-title":"CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs.","volume":"13","author":"Dudekula","year":"2016","journal-title":"RNA Biol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-981-13-1426-1_6","article-title":"Circular RNAs Act as miRNA Sponges.","volume":"1087","author":"Panda","year":"2018","journal-title":"Adv Exp Med Biol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"903","DOI":"10.18632\/aging.100834","article-title":"Circular RNAs in monkey muscle: age-dependent changes.","volume":"7","author":"Abdelmohsen","year":"2015","journal-title":"Aging (Albany NY)."},{"key":"B103","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/15476286.2017.1279788","article-title":"Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1.","volume":"14","author":"Abdelmohsen","year":"2017","journal-title":"RNA Biol."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx297","article-title":"High-purity circular RNA isolation method (RPAD) reveals vast collection of intronic circRNAs.","volume":"45","author":"Panda","year":"2017","journal-title":"Nucleic Acids Res."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01742\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:59:36Z","timestamp":1599613176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01742\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,9]]},"references-count":104,"alternative-id":["10.3389\/fonc.2020.01742"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.01742","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,9]]},"article-number":"1742"}}